Trump's Drug Price Deal with Regeneron

Regeneron is the 17th major drugmaker to reach such a deal with the administration ahead of the midterm elections.

Under the terms, the company will offer significant discounts on its products and provide a new hearing-loss therapy at no cost.

Trump touted the agreement as the 'biggest price reduction in history,' though some health experts have questioned his mathematical claims.

The president also highlighted his administration's move to reclassify medical marijuana during the same White House event.